Actinogen Medical (ASX:ACW) tackling Alzheimer's by inhibiting excess cortisol production in the brain

Published: Nov. 8, 2020, 10:55 p.m.

11 Nov 2020 - Actinogen Medical Limited (ASX:ACW) Managing Director and CEO Dr Bill Ketelbey provides an update on the company, discussing its lead drug candidate Xanamem, clinical trial roadmap and entitlement offer to raise up to $4.9m.